Track 1: Biomarkers in Drug Development 

• Biomarkers for drug safety assessment
• Biomarkers in clinical trials
• Translational biomarkers
• Personalized medicine

Track 2: Molecular Diagnostics 

• Biomarker assay development
• Laboratory-developed tests
• Next-generation "Omics" diagnostics

Track 3: Executive Summit: Drug-Diagnostic Co-Development 

• Drug-diagnostic co-development case studies
• Partnering strategies
• Regulatory requirements for companion diagnostics

 Felix W. Frueh, Ph.D., President, Medco Research Institute, Medco Health Solutions, Inc.

 Nicholas C. Dracopoli, Ph.D., Vice President, Biomarkers, Centocor R&D, Johnson & Johnson

 Geert Kolvenbag, M.D., Ph.D., Vice President,
Global Product, AstraZeneca

For more details on the conference, please contact: 
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
T: 760-732-3139
E: juliab@healthtech.com 

For exhibit & sponsorship opportunities, please contact: 
Ilana Quigley
Manager, Business Development
Cambridge Healthtech Institute
T: 781-972-5457
E: iquigley@healthtech.com

For media and association partnerships, please contact: 
Rich Handy
Senior Director, Marketing
Cambridge Healthtech Institute
T: 781.972.5456
E: rhandy@healthtech.com